A critical breakthrough in cancer study is occurring with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant protector protein is frequently disabled in several forms of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research